These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18313839)

  • 1. Mutations of the lutropin/choriogonadotropin receptor that do not activate the phosphoinositide cascade allow hCG to induce aromatase expression in immature rat granulosa cells.
    Andric N; Ascoli M
    Mol Cell Endocrinol; 2008 Mar; 285(1-2):62-72. PubMed ID: 18313839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The differential effects of the gonadotropin receptors on aromatase expression in primary cultures of immature rat granulosa cells are highly dependent on the density of receptors expressed and the activation of the inositol phosphate cascade.
    Donadeu FX; Ascoli M
    Endocrinology; 2005 Sep; 146(9):3907-16. PubMed ID: 15919743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lutropin/choriogonadotropin receptor-induced phosphorylation of the extracellular signal-regulated kinases in leydig cells is mediated by a protein kinase a-dependent activation of ras.
    Hirakawa T; Ascoli M
    Mol Endocrinol; 2003 Nov; 17(11):2189-200. PubMed ID: 12920236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A delayed gonadotropin-dependent and growth factor-mediated activation of the extracellular signal-regulated kinase 1/2 cascade negatively regulates aromatase expression in granulosa cells.
    Andric N; Ascoli M
    Mol Endocrinol; 2006 Dec; 20(12):3308-20. PubMed ID: 16973759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lutropin/choriogonadotropin stimulate the proliferation of primary cultures of rat Leydig cells through a pathway that involves activation of the extracellularly regulated kinase 1/2 cascade.
    Shiraishi K; Ascoli M
    Endocrinology; 2007 Jul; 148(7):3214-25. PubMed ID: 17412805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotropic effects of substitutions of a highly conserved leucine in transmembrane helix III of the human lutropin/choriogonadotropin receptor with respect to constitutive activation and hormone responsiveness.
    Shinozaki H; Fanelli F; Liu X; Jaquette J; Nakamura K; Segaloff DL
    Mol Endocrinol; 2001 Jun; 15(6):972-84. PubMed ID: 11376115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of activating and inactivating mutations on the phosphorylation and trafficking of the human lutropin/choriogonadotropin receptor.
    Min L; Ascoli M
    Mol Endocrinol; 2000 Nov; 14(11):1797-810. PubMed ID: 11075813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences between lutropin-mediated and choriogonadotropin-mediated receptor activation.
    Grzesik P; Teichmann A; Furkert J; Rutz C; Wiesner B; Kleinau G; Schülein R; Gromoll J; Krause G
    FEBS J; 2014 Mar; 281(5):1479-1492. PubMed ID: 24438591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transactivation of the epidermal growth factor receptor is involved in the lutropin receptor-mediated down-regulation of ovarian aromatase expression in vivo.
    Andric N; Thomas M; Ascoli M
    Mol Endocrinol; 2010 Mar; 24(3):552-60. PubMed ID: 20093417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LH and hCG action on the same receptor results in quantitatively and qualitatively different intracellular signalling.
    Casarini L; Lispi M; Longobardi S; Milosa F; La Marca A; Tagliasacchi D; Pignatti E; Simoni M
    PLoS One; 2012; 7(10):e46682. PubMed ID: 23071612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-independent precocious puberty due to luteinizing hormone receptor mutations in Brazilian boys: a novel constitutively activating mutation in the first transmembrane helix.
    Latronico AC; Shinozaki H; Guerra G; Pereira MA; Lemos Marini SH; Baptista MT; Arnhold IJ; Fanelli F; Mendonca BB; Segaloff DL
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4799-805. PubMed ID: 11134146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desensitization of Gs-coupled receptor signaling by constitutively active mutants of the human lutropin/choriogonadotropin receptor.
    Shinozaki H; Butnev V; Tao YX; Ang KL; Conti M; Segaloff DL
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1194-204. PubMed ID: 12629106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for dual coupling of the murine luteinizing hormone receptor to adenylyl cyclase and phosphoinositide breakdown and Ca2+ mobilization. Studies with the cloned murine luteinizing hormone receptor expressed in L cells.
    Gudermann T; Birnbaumer M; Birnbaumer L
    J Biol Chem; 1992 Mar; 267(7):4479-88. PubMed ID: 1311310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of the second extracellular loop of the human lutropin receptor emphasize the importance of receptor activation and de-emphasize the importance of receptor phosphorylation in agonist-induced internalization.
    Li S; Liu X; Min L; Ascoli M
    J Biol Chem; 2001 Mar; 276(11):7968-73. PubMed ID: 11118455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arrestin-3 is essential for the activation of Fyn by the luteinizing hormone receptor (LHR) in MA-10 cells.
    Galet C; Ascoli M
    Cell Signal; 2008 Oct; 20(10):1822-9. PubMed ID: 18647647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A homozygous microdeletion in helix 7 of the luteinizing hormone receptor associated with familial testicular and ovarian resistance is due to both decreased cell surface expression and impaired effector activation by the cell surface receptor.
    Latronico AC; Chai Y; Arnhold IJ; Liu X; Mendonca BB; Segaloff DL
    Mol Endocrinol; 1998 Mar; 12(3):442-50. PubMed ID: 9514160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cell surface inactive mutant of the human lutropin receptor (hLHR) attenuates signaling of wild-type or constitutively active receptors via heterodimerization.
    Zhang M; Feng X; Guan R; Hébert TE; Segaloff DL
    Cell Signal; 2009 Nov; 21(11):1663-71. PubMed ID: 19616090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The postendocytotic trafficking of the human lutropin receptor is mediated by a transferable motif consisting of the C-terminal cysteine and an upstream leucine.
    Galet C; Hirakawa T; Ascoli M
    Mol Endocrinol; 2004 Feb; 18(2):434-46. PubMed ID: 14605099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A co-culture system reveals the involvement of intercellular pathways as mediators of the lutropin receptor (LHR)-stimulated ERK1/2 phosphorylation in Leydig cells.
    Shiraishi K; Ascoli M
    Exp Cell Res; 2008 Jan; 314(1):25-37. PubMed ID: 17727840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive cytoplasmic tail truncations of the lutropin-choriogonadotropin receptor prevent agonist- or phorbol ester-induced phosphorylation, impair agonist- or phorbol ester-induced desensitization, and enhance agonist-induced receptor down-regulation.
    Wang Z; Hipkin RW; Ascoli M
    Mol Endocrinol; 1996 Jun; 10(6):748-59. PubMed ID: 8776735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.